Level Up your Documentation Processes and Systems to Comply with FDA Final Rule Stages 1 & 2
FDA’s ruling on enforcement of in vitro diagnostic (IVD) medical device requirements for...
See Velsera in action.
Blog
Insights from Velsera.
Enhancing the Precision Medicine Journey
Five Focus Areas for Our Chief Customer Officer
Get Ready to Comply with FDA Final Rule Stages 1 & 2: Yeah, We Mean You
FDA's New LDT Rule: An Overview
EXPLORE OUR PRODUCTS
Document library.
BROCHURE
The Seven Bridges Platform
Accelerating your drug discovery process with Velsera's enterprise-grade bioinformatics ecosystem.
BROCHURE
GRAF
A better approach to NGS data analysis: building a pan-genome graph containing population genetics.
BROCHURE
ARIA
Robust analysis on integrated genomic and phenotypic data.
BROCHURE
Clinical Genomics Workspace
All-in-one analysis and reporting tool for clinical NGS data, enhancing the quality and efficiency of patient care delivery.
BROCHURE
FastFinder
A secure and reliable platform for molecular diagnostics.
TECHNICAL NOTE
Clinical Genomics Knowledgebase
Identify clinically significant variants and produce an actionable report.
on-demand
Video library.
April 3, 2024
Accelerating Drug Discovery: How GRAF Pangenomes Enable Enhanced Insights From Sequencing Data.
Uncover solutions to the pressing challenges in Next-Generation Sequencing (NGS) data analysis with Velsera. Join our upcoming webinar to address a pivotal pain point in genomics: reference bias. Learn how Velsera's GRAF solution tackles reference bias and seamlessly integrates with existing pipelines, lowering computational costs and elevating your NGS analysis efficiency.
watch here
February 29, 2024
State of the Union: NGS Reimbursement.
In the recorded session, you will learn about how the new 2024 CPT codes may impact your organization's reimbursement rates, current trends for NGS reimbursement, the Medicare Gapfill process and more!
watch here
October 13, 2023
Unleashing the Power of Neoantigens: Bridging Discovery, Cutting-Edge Scientific Breakthroughs and Medical Innovation.
Julie Gil, Senior Scientific Partner at Velsera, explores the frontier of bioinformatics and immunology. In this illuminating talk, Julie explores the groundbreaking world of neoantigens, revealing how they hold the key to revolutionizing the fields of immunotherapy and personalized medicine.
watch here
April 3, 2024
Accelerating Drug Discovery: How GRAF Pangenomes Enable Enhanced Insights From Sequencing Data.
Uncover solutions to the pressing challenges in Next-Generation Sequencing (NGS) data analysis with Velsera. Join our upcoming webinar to address a pivotal pain point in genomics: reference bias. Learn how Velsera's GRAF solution tackles reference bias and seamlessly integrates with existing pipelines, lowering computational costs and elevating your NGS analysis efficiency.
watch here
February 29, 2024
State of the Union: NGS Reimbursement.
In the recorded session, you will learn about how the new 2024 CPT codes may impact your organization's reimbursement rates, current trends for NGS reimbursement, the Medicare Gapfill process and more!
watch here
October 13, 2023
Unleashing the Power of Neoantigens: Bridging Discovery, Cutting-Edge Scientific Breakthroughs and Medical Innovation.
Julie Gil, Senior Scientific Partner at Velsera, explores the frontier of bioinformatics and immunology. In this illuminating talk, Julie explores the groundbreaking world of neoantigens, revealing how they hold the key to revolutionizing the fields of immunotherapy and personalized medicine.
watch here
SEE VELSERA IN ACTION
Ask what’s possible with Velsera.
